WallStreetZenWallStreetZen

NASDAQ: HSIC
Henry Schein Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Henry Schein earnings were $389.0M for the trailing 12 months ending Jun 28, 2025, with 15% growth year over year. The latest HSIC earnings report on Jun 28, 2025 announced Q2 2025 earnings of $86.0M, down 21.8% from last quarter. For the last reported fiscal year 2024 ending Dec 28, 2024, HSIC reported annual earnings of $390.0M, with -6.3% growth. The next HSIC earnings date is Nov 4, 2025.

HSIC past earnings growth

How has HSIC's earnings growth performed historically?

Company
15.02%
Industry
23.99%
Market
29.72%
HSIC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HSIC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HSIC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HSIC earnings history

Current Revenue
$12.8B
Current Earnings
$389.0M
Current Profit Margin
3%
HSIC's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

HSIC Return on Equity

Current Company
11.4%
Current Industry
-11.1%
Current Market
31.1%
HSIC's Return on Equity (11.4%)... subscribe to Premium to read more.
High Return on Equity Performance

HSIC undefined

Current Company
3.7%
Current Industry
3.4%
HSIC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HSIC announces earnings.

HSIC undefined

Current Company
8.36%
Current Industry
19.2%
HSIC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HSIC vs Medical Distribution Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HSIC$959.00M$389.00M-4.87%$3.14
AHG-$163.73M-$134.98MN/A-$0.48
OMI-$839.13M-$1.20BN/A-$15.65
EDAPN/A-$24.43MN/A-$0.66
ZYXI-$16.64M-$28.66MN/A-$0.94
View Top Medical Distribution Stocks

HSIC earnings dates

Next earnings date
Nov 4, 2025

Henry Schein Earnings Reports & History FAQ

What were Henry Schein's earnings last quarter?

On HSIC's earnings call on Invalid Date, Henry Schein (NASDAQ: HSIC) reported Q2 2025 earnings per share (EPS) of $0.71, up 12.35% year over year. Total HSIC earnings for the quarter were $86.00 million. In the same quarter last year, Henry Schein's earnings per share (EPS) was $0.81.

If you're new to stock investing, here's how to buy Henry Schein stock.

When does Henry Schein report earnings?

The next HSIC earnings date is Invalid Date. Add HSIC to your watchlist to be reminded of Henry Schein's next earnings date.

Is Henry Schein profitable or losing money?

As of the last Henry Schein earnings report, Henry Schein is currently profitable. Henry Schein's net profit (also called net income) for the twelve months ending Jun 28, 2025 was $389.00 million, a 10.51% increase year over year.

What was HSIC's earnings growth in the past year?

As of Henry Schein's earnings date in Invalid Date, Henry Schein's earnings has grown 15.02% year over year. This is 8.98 percentage points lower than the US Medical Distribution industry earnings growth rate of 23.99%. HSIC earnings in the past year totalled $389.00 million.

What are Henry Schein's earnings expectations?

The current EPS estimate for Henry Schein's earnings report in Invalid Date is $1.28.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.